medigraphic.com
SPANISH

Revista Clínica de la Escuela de Medicina de la Universidad de Costa Rica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back Next >>

Rev Clin Esc Med 2016; 6 (1)

Síndrome de Ovario Poliquistico

Borbón CMF, Robles QF
Full text How to cite this article

Language: Spanish
References: 10
Page: 134-137
PDF size: 755.08 Kb.


Key words:

Polycystic ovary syndrome, acne, hirsutism, insulin resistance, menstrual irregularity, pattern alopecia.

ABSTRACT

Polycystic ovary syndrome affects 5% to 10% of reproductive-age women and it is one of the most common endocrine disorders in women. It is a heterogeneous syndrome of hyperandrogenic anovulation that is typically due to intrinsic ovarian dysfunction. Although patients affected are often very disturbed by the cutaneous manifestations, including acne, hirsutism, alopecia and acanthosis nigricans, the clinical manifestations of polycystic ovary syndrome ramify far beyond the skin. Polycystic ovary syndrome frequently causes menstrual abnormalities and infertility. This syndrome is often aggravated by insulinresistant hyperinsulinemia with its risks of diabetes mellitus and metabolic syndrome and their complications. Among the most important factors in their approach is the reduction in weight as well as the desire to conceive, treatment is decided based on these points.


REFERENCES

  1. Ermaanh D. Polycystic ovary syndrome review. N Engl J Med. 2005;352:1223- 36.

  2. Guzick DS Wing R Smith D Berga SL Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril. 1994;61:598-604

  3. King J. Polycystyc ovary syndrome. J Midwifery Womens Health. 2006;51:415-22.

  4. The Rotterdam ESHRE/ASRMsponsered PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19:41-7.

  5. Chang R. A practical approach to the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol. 2004;191:713-7.

  6. Brewer M Pawelczak M Kessler M Shah B. A review of polycystic ovarian syndrome in adolescents. Minerva Pediatr. 2010;62:459-73.

  7. Jonard S Roberty Y Cortet-Rudelli C Pigny P Decantec D. Ultrasound examination in polycystic ovary syndrome. Is it worth to count follicles? Hum Reprod. 2003;18:598-603.

  8. Nam MM Strauss JF. Genetics of polycystic ovarian syndrome. Clin Obstet Gynecol. 2007;50:188-204

  9. Rosenfield RL. What every physician should know about polycystic ovary syndrome. Dermatol Ther. 2008;21:354- 61.

  10. Stein I Leventhal M. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-5.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Clin Esc Med. 2016;6